Today: 20 May 2026
Marks & Spencer (MKS.L) shares fall as Jan 8 Christmas trading update looms
6 January 2026
1 min read

Marks & Spencer (MKS.L) shares fall as Jan 8 Christmas trading update looms

London, January 6, 2026, 10:16 GMT — Regular session

  • Marks and Spencer shares fall 1.6% in early London trade, hovering near the year’s low.
  • Industry data showed M&S grocery sales up 7.2% over the past 12 weeks as UK grocery inflation eased in December.
  • Traders are positioning for M&S’s Christmas trading statement due on Thursday.

Shares in Marks and Spencer Group plc (MKS.L) fell 1.6% to 317.5 pence by 10:16 GMT on Tuesday, down 5.2 pence from the previous close. The stock traded between 316.46 and 327.60 pence, and is edging just above its 52-week low of 315.30.

The slide comes ahead of a key seasonal read. M&S is due to publish its Christmas trading update on Thursday, Jan. 8, a statement investors use to gauge holiday demand and any knock-on effects for profit guidance — the company’s forecast for earnings.

UK apparel peers delivered an early signal on Tuesday. Next said it lifted its annual profit forecast after a 10.6% rise in full-price Christmas sales, pushing its shares up 3.1%. “This tough backdrop may make future upgrades harder to come by,” Shore Capital analyst David Hughes said. Reuters

Food data pointed in a steadier direction. Worldpanel by Numerator said M&S grocery sales rose 7.2% over the 12 weeks to Dec. 28, while UK grocery inflation eased to 4.3% in December — an early indication ahead of official UK inflation data due on Jan. 21. Overall grocery sales were 13.8 billion pounds in the four weeks to Dec. 28, up 3.8% year on year, but volumes fell once inflation was stripped out, it said.

M&S straddles two very different engines: food, where it has been gaining ground, and clothing and home, which is more exposed to weather swings and discretionary spending.

Thursday’s statement is expected to sharpen the debate over mix and margins. Traders will focus on whether strong top-line sales translated into profit once promotions, or price cuts, are taken into account.

Investors will also listen for signals on inventory and markdown risk into January, when many retailers clear seasonal stock. A cautious tone on forward demand can weigh heavily on shares after the Christmas quarter.

Technically, the shares are sitting close to the 315 pence area after retreating roughly a quarter from their 52-week high. A break lower would put the year’s floor back in play, while a rebound would need to reclaim the prior close near 323 pence.

But the read-through can cut both ways. Strong sales can still disappoint if discounting and costs squeeze margins, and easing food inflation can reduce price-led growth even if it helps shopper demand.

Stock Market Today

  • Top 5 Big Data Stocks to Watch as Wall Street Advances
    May 20, 2026, 9:35 AM EDT. Big Data companies process and analyze vast diverse datasets, fueling tech growth on Wall Street. Key players include Cisco Systems (CSCO), Salesforce (CRM), Palantir (PLTR), Cloudflare (NET), and Datadog (DDOG), all rated Zacks Rank #2 (Buy). Cisco leads with record revenues driven by strong AI-driven data center orders, projecting a 4.5x rise in AI infrastructure sales by fiscal 2026 while cutting 4,000 jobs to focus on AI and security. Salesforce accelerates investments in generative AI with its Einstein GPT platform and a venture fund targeting AI innovation, especially in Europe. These stocks exemplify the sector's growth potential amid the ongoing tech rally.

Latest articles

ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio’s FDA Deadline Could Change Its Bladder-Cancer Story—But the Risk Is Still There

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
AmpliTech Jumps After 5G Approval Clears North America Sales Path

AmpliTech Jumps After 5G Approval Clears North America Sales Path

20 May 2026
AmpliTech received U.S. and Canadian certification for its full indoor 5G Native DAS hardware, enabling immediate commercial sales and integration across North America. Shares rose about 14% in premarket trading after the announcement. The company said it has orders from a North American mobile network operator, with shipments set to begin later this year.
Intuit’s Q3 Numbers Land as Shares Down 39%

Intuit’s Q3 Numbers Land as Shares Down 39%

20 May 2026
Intuit will report fiscal third-quarter results after U.S. markets close Wednesday, following a 39% stock drop over the past year. Analysts expect earnings of $12.57 per share on $8.54 billion revenue, both up from last year. The quarter covers peak tax season for TurboTax and QuickBooks. Intuit shares closed at $399.71 Tuesday, down 0.9%.
Why Commonwealth Bank (ASX:CBA) shares fell 3% as Australia’s CPI test nears
Previous Story

Why Commonwealth Bank (ASX:CBA) shares fell 3% as Australia’s CPI test nears

Dow Jones today: Futures dip after record close as U.S. jobs report looms
Next Story

Dow Jones today: Futures dip after record close as U.S. jobs report looms

Go toTop